Subjects

Abstract

The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype. In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3. This region contains the gene SCN9A, encoding the α-subunit of the voltage-gated sodium channel, Nav1.7, which is strongly expressed in nociceptive neurons. Sequence analysis of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X). We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Nav1.7 with sodium channel β1 and β2 subunits in HEK293 cells. In cells expressing mutant Nav1.7, the currents were no greater than background. Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans. These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Dearborn, G. A case of congenital general pure analgesia. J. Nerv. Ment. Dis. 75, 612–615 (1932)

  2. 2

    Dyck, P. J. et al. Not ‘indifference to pain’ but varieties of hereditary sensory and autonomic neuropathy. Brain 106, 373–390 (1983)

  3. 3

    Landrieu, P., Said, G. & Allaire, C. Dominantly transmitted congenital indifference to pain. Ann. Neurol. 27, 574–578 (1990)

  4. 4

    Nagasako, E. M., Oaklander, A. L. & Dworkin, R. H. Congenital insensitivity to pain: an update. Pain 101, 213–219 (2003)

  5. 5

    Klein, C. J., Sinnreich, M. & Dyck, P. J. Indifference rather than insensitivity to pain. Ann. Neurol. 53, 417–418 (2003); author reply Ann. Neurol. 53, 418–419 (2003)

  6. 6

    Klugbauer, N., Lacinova, L., Flockerzi, V. & Hofmann, F. Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J. 14, 1084–1090 (1995)

  7. 7

    Toledo-Aral, J. J. et al. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc. Natl Acad. Sci. USA 94, 1527–1532 (1997)

  8. 8

    Sangameswaran, L. et al. A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J. Biol. Chem. 272, 14805–14809 (1997)

  9. 9

    Rush, A. M. et al. A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc. Natl Acad. Sci. USA 103, 8245–8250 (2006)

  10. 10

    Amir, R. et al. The role of sodium channels in chronic inflammatory and neuropathic pain. J. Pain 7, S1–29 (2006)

  11. 11

    Cummins, T. R., Howe, J. R. & Waxman, S. G. Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J. Neurosci. 18, 9607–9619 (1998)

  12. 12

    Amrani, N., Sachs, M. S. & Jacobson, A. Early nonsense: mRNA decay solves a translational problem. Nature Rev. Mol. Cell Biol. 7, 415–425 (2006)

  13. 13

    Black, J. A. et al. Spinal sensory neurons express multiple sodium channel α-subunit mRNAs. Brain Res. Mol. Brain Res. 43, 117–131 (1996)

  14. 14

    Catterall, W. A. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26, 13–25 (2000)

  15. 15

    Isom, L. L. Sodium channel β subunits: anything but auxiliary. Neuroscientist 7, 42–54 (2001)

  16. 16

    Cummins, T. R., Dib-Hajj, S. D. & Waxman, S. G. Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J. Neurosci. 24, 8232–8236 (2004)

  17. 17

    Catterall, W. A., Goldin, A. L. & Waxman, S. G. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 57, 397–409 (2005)

  18. 18

    Herzog, R. I., Cummins, T. R., Ghassemi, F., Dib-Hajj, S. D. & Waxman, S. G. Distinct repriming and closed-state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons. J. Physiol. (Lond.) 551, 741–750 (2003)

  19. 19

    Renganathan, M., Cummins, T. R. & Waxman, S. G. Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons. J. Neurophysiol. 86, 629–640 (2001)

  20. 20

    Blair, N. T. & Bean, B. P. Roles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons. J. Neurosci. 22, 10277–10290 (2002)

  21. 21

    Raymond, C. K. et al. Expression of alternatively spliced sodium channel α-subunit genes. Unique splicing patterns are observed in dorsal root ganglia. J. Biol. Chem. 279, 46234–46241 (2004)

  22. 22

    Yang, Y. et al. Mutations in SCN9A, encoding a sodium channel α subunit, in patients with primary erythermalgia. J. Med. Genet. 41, 171–174 (2004)

  23. 23

    Dib-Hajj, S. D. et al. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain 128, 1847–1854 (2005)

  24. 24

    Han, C. et al. Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7. Ann. Neurol. 59, 553–558 (2006)

  25. 25

    Nassar, M. A. et al. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc. Natl Acad. Sci. USA 101, 12706–12711 (2004)

  26. 26

    Nassar, M. A., Levato, A., Stirling, L. C. & Wood, J. N. Neuropathic pain develops normally in mice lacking both Nav1.7 and Nav1.8. Mol. Pain 1, 24 (2005)

  27. 27

    Akopian, A. N., Abson, N. C. & Wood, J. N. Molecular genetic approaches to nociceptor development and function. Trends Neurosci. 19, 240–246 (1996)

  28. 28

    Scholz, J. & Woolf, C. J. Can we conquer pain?. Nature Neurosci. 5, (Suppl)1062–1067 (2002)

Download references

Acknowledgements

We thank the families who participated in this study, A. Boylston for critical advice, and Pfizer, the Wellcome Trust and St John’s College, Cambridge for funding. Author Contributions This study was designed by J.J.C., F.R., E.R., R.W., D.P.M., F.M.G. and C.G.W.; patient identification and phenotype assessment was performed by G.K., H.J., J.M., Y.R., L.A.-G., H.H., E.M.V., S.G. and C.G.W.; DNA extraction, linkage analysis, bioinformatics and sequencing was performed by J.J.C., A.K.N., E.R., K.S. and C.G.W.; cloning was performed by J.J.C.; electrophysiology was performed by F.R. and F.M.G.; and the paper was written by J.J.C., F.R., G.T., J.N.W., F.M.G. and C.G.W.

Author information

Author notes

  1. James J. Cox and Frank Reimann: These authors contributed equally to this work.

Affiliations

  1. Department of Medical Genetics

    • James J. Cox
    • , Adeline K. Nicholas
    • , Gemma Thornton
    •  & C. Geoffrey Woods
  2. Department of Clinical Biochemistry, Cambridge Institute for Medical Research, Wellcome/MRC Building, Addenbrooke’s Hospital, Cambridge, CB2 0XY, UK

    • Frank Reimann
    •  & Fiona M. Gribble
  3. Section of Ophthalmology and Neuroscience Leeds Institute of Molecular Medicine

    • Emma Roberts
    •  & Kelly Springell
  4. Department of Clinical Genetics, St James’s University Hospital, Leeds, LS9 7TF, UK

    • Gulshan Karbani
  5. Gene Tech Lab 146/1, Shadman Jail Road, Lahore, Pakistan

    • Hussain Jafri
  6. Department of Paediatrics, Fatima Jinah Medical College, Lahore, Pakistan

    • Jovaria Mannan
  7. Department of Obstetrics and Gynaecology, King Edward Medical University, Lahore, Pakistan

    • Yasmin Raashid
  8. Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al-Anin, P O Box 15551, United Arab Emirates

    • Lihadh Al-Gazali
  9. National Center for Diabetes, Endocrinology and Genetics, P O Box 3165/11942, Amman, Jordan

    • Henan Hamamy
  10. IRCCS CSS, San Giovanni Rotondo and CSS Mendel, Rome, I-00168, Italy

    • Enza Maria Valente
  11. Department of Paediatrics, St Luke’s Hospital, Bradford, BD5 0NA, UK

    • Shaun Gorman
  12. Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, CT13 9NJ, UK

    • Richard Williams
    •  & Duncan P. McHale
  13. Molecular Nociception Group, Department of Biology, University College London, London, WC1E 6BT, UK

    • John N. Wood

Authors

  1. Search for James J. Cox in:

  2. Search for Frank Reimann in:

  3. Search for Adeline K. Nicholas in:

  4. Search for Gemma Thornton in:

  5. Search for Emma Roberts in:

  6. Search for Kelly Springell in:

  7. Search for Gulshan Karbani in:

  8. Search for Hussain Jafri in:

  9. Search for Jovaria Mannan in:

  10. Search for Yasmin Raashid in:

  11. Search for Lihadh Al-Gazali in:

  12. Search for Henan Hamamy in:

  13. Search for Enza Maria Valente in:

  14. Search for Shaun Gorman in:

  15. Search for Richard Williams in:

  16. Search for Duncan P. McHale in:

  17. Search for John N. Wood in:

  18. Search for Fiona M. Gribble in:

  19. Search for C. Geoffrey Woods in:

Competing interests

The sequence for full-length human SCN9A cloned from fetal brain mRNA is deposited in GenBank under accession number DQ857292. Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.

Corresponding author

Correspondence to C. Geoffrey Woods.

Supplementary information

  1. Supplementary Information

    This file contains Supplementary Methods discussing cloning methodology used to generate the constructs for this study, Supplementary Figures 1- 2 and Supplementary Tables 1-2. Supplementary Figure 1 shows kinetic properties of whole cell wild-type NaV1.7+NaVβ1+NaVβ2 currents in HEK293 cells. Supplementary Figure 2 shows alignment of the amino acid sequences of the corresponding common splice variants for the human (NP_002968) and mouse Nav1.7 (XP_904764) proteins using the LALIGN program (: = identical amino acid; . = similar amino acid). Supplementary Table 1 shows markers used to search for common haplotype blocks between the three families.Supplementary Table 2 shows primers used to amplify and sequence the coding exons and splice sites of SCN9A (PDF 5083 kb)

About this article

Publication history

Received

Accepted

Issue Date

DOI

https://doi.org/10.1038/nature05413

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.